Ernest Nadal
Ernest Nadal (Catalan Institute of Oncology (ICO); Bellvitge Biomedical Research Institute (IDIBELL); L'Hospitalet, Barcelona, Spain)
- Head of the Section of Thoracic Tumors, Department of Medical Oncology, Catalan Institute of Oncology, L’Hospitalet, Barcelona, Spain
- Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge, L’Hospitalet, Barcelona, Spain
- Principal Investigator of the Preclinical and Experimental Research in Thoracic Tumors (PReTT) group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet, Barcelona, Spain
Ernest Nadal obtained his MD degree in 2001 at the University of Valencia (Spain) and completed his training in Medical Oncology in 2006 at the Catalan Institute of Oncology (Barcelona, Spain). He completed his training in translational research at the University of Michigan (Ann Arbor, US) and returned to the Catalan Institute of Oncology in 2014 where he leads the Section of Thoracic Tumors and the Preclinical and Experimental Research in Thoracic Tumors (PRETT) Group at IDIBELL.
The main research interests are the development of clinical trials in special populations of patients with thoracic malignancies, the study of novel therapeutic strategies in malignant pleural mesothelioma, the characterization of the immune contexture of brain metastases and the genomic characterization of early onset lung cancer patients. He published more than 100 papers including papers in high impact journals in the field of oncology or cancer biology.
- Head of the Section of Thoracic Tumors, Department of Medical Oncology, Catalan Institute of Oncology, L’Hospitalet, Barcelona, Spain
- Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge, L’Hospitalet, Barcelona, Spain
- Principal Investigator of the Preclinical and Experimental Research in Thoracic Tumors (PReTT) group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet, Barcelona, Spain
Ernest Nadal obtained his MD degree in 2001 at the University of Valencia (Spain) and completed his training in Medical Oncology in 2006 at the Catalan Institute of Oncology (Barcelona, Spain). He completed his training in translational research at the University of Michigan (Ann Arbor, US) and returned to the Catalan Institute of Oncology in 2014 where he leads the Section of Thoracic Tumors and the Preclinical and Experimental Research in Thoracic Tumors (PRETT) Group at IDIBELL.
The main research interests are the development of clinical trials in special populations of patients with thoracic malignancies, the study of novel therapeutic strategies in malignant pleural mesothelioma, the characterization of the immune contexture of brain metastases and the genomic characterization of early onset lung cancer patients. He published more than 100 papers including papers in high impact journals in the field of oncology or cancer biology.
